Abstract Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease
caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to …

Recommendations for the clinical and laboratory diagnosis of vaccine‐induced immune
thrombotic thrombocytopenia (VITT) for SAR Page 1 Accepted Article This article has been …

INTRODUCTION—Vaccination is considered the most promising approach for ending or
containing the coronavirus disease 2019 (COVID-19) pandemic. Available vaccines have …

Objectives: Review the epidemiology of VITT. Describe the pathophysiology and pertinent
clinical features of VITT. Review the treatment options in the management of VITT. Describe …

In response to the COVID-19 pandemic, several vaccines were developed and rolled out at
unprecedented speed, and notwithstanding this rapid pace of development, the results from …

Objectives To meta-analyse the clinical manifestations, diagnosis, treatment, and mortality of
vaccine-induced immune thrombotic thrombocytopenia (VITT) after adenoviral vector …

Vaccine-induced immune thrombotic thrombocytopenia (VITT) has been reported in
association with the coronavirus disease 2019 preventative adenovirus vector-based …

Vaccine administration is under way worldwide to combat the current COVID‐19 pandemic.
The newly developed vaccines are highly effective with minimal adverse effects. Recently …

Recently Journal of Thrombosis and Haemostatis (JTH) published the updated
recommendations for diagnosis and management of vaccine-induced immune thrombotic …

Introduction Vaccine-induced thrombotic thrombocytopenia (VITT) has been identified as a
rare but serious adverse event associated with coronavirus disease 2019 (COVID-19) …